BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 29346528)

  • 1. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
    Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
    Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma.
    Zhang D; Song Y; Li D; Liu X; Pan Y; Ding L; Shi G; Wang Y; Ni Y; Hou Y
    Mol Oncol; 2022 Feb; 16(3):780-794. PubMed ID: 33657265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway.
    Yang J; Shi X; Yang M; Luo J; Gao Q; Wang X; Wu Y; Tian Y; Wu F; Zhou H
    Int J Oral Sci; 2021 Mar; 13(1):12. PubMed ID: 33762576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished CD68
    Zhao X; Ding L; Lu Z; Huang X; Jing Y; Yang Y; Chen S; Hu Q; Ni Y
    Am J Pathol; 2020 Apr; 190(4):886-899. PubMed ID: 32035062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
    Kartha VK; Stawski L; Han R; Haines P; Gallagher G; Noonan V; Kukuruzinska M; Monti S; Trojanowska M
    PLoS One; 2016; 11(4):e0154645. PubMed ID: 27128408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
    Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
    J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis.
    Wang Y; Zhang X; Wang Z; Hu Q; Wu J; Li Y; Ren X; Wu T; Tao X; Chen X; Li X; Xia J; Cheng B
    Cancer Lett; 2018 Oct; 434():172-183. PubMed ID: 30026052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery.
    Hu T; Hu J
    Cell Cycle; 2019 Nov; 18(22):3085-3094. PubMed ID: 31544590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
    Yang W; Zhang S; Li T; Zhou Z; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
    J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma
    Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS; Kwon TG; Kim JW; Lee ST; Choi SY; Hong SH
    Theranostics; 2024; 14(2):460-479. PubMed ID: 38169528
    [No Abstract]   [Full Text] [Related]  

  • 16. Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression.
    Bae JY; Kim EK; Yang DH; Zhang X; Park YJ; Lee DY; Che CM; Kim J
    Neoplasia; 2014 Nov; 16(11):928-38. PubMed ID: 25425967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Squamous Cell Carcinoma-Derived ANGPTL3 Induces Cancer Associated Fibroblastic Phenotypes in Surrounding Fibroblasts.
    Kim JY; Moon S; Kim D
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4315-4322. PubMed ID: 36580015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
    Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
    Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
    Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
    Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
    Yang B; Zhang L; Cao Y; Chen S; Cao J; Wu D; Chen J; Xiong H; Pan Z; Qiu F; Chen J; Ling X; Yan M; Huang S; Zhou S; Li T; Yang L; Huang Y; Lu J
    Mol Cancer; 2017 Sep; 16(1):154. PubMed ID: 28946875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.